Skip to main content
Fig. 1 | Journal of Nanobiotechnology

Fig. 1

From: The anti-tumor and renoprotection study of E-[c(RGDfK)2]/folic acid co-modified nanostructured lipid carrier loaded with doxorubicin hydrochloride/salvianolic acid A

Fig. 1

The morphological characteristics of NLC-Sal A/DOX (a), FA-NLC-Sal A/DOX (b), E-[c(RGDfK)2]-NLC-Sal A/DOX (c) and E-[c(RGDfK)2]/FA-NLC-Sal A/DOX (d); DSC results of different formations (e); XRD patterns of different formations (f). A: DOX reference substance, B: Sal A reference substance, C: Blank-NLC, D: mixture of A-C (w/w, A:B:C = 1:1:1), E: NLC-Sal A/DOX, F: FA-NLC-Sal A/DOX, G: E-[c(RGDfK)2]-NLC-Sal A/DOX, H: E-[c(RGDfK)2]/FA-NLC-Sal A/DOX

Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us